10th EMIM European Molecular Imaging Meeting
New! The 10th
EMIM European Molecular Imaging Meeting will take place on 18-20 March 2015 in
Abstract Submission will open on 3rd November. Learn more on the event website !
TOPIM Meeting on Imaging Inflammation
New! TOPIM stands for
“hot TOPics in molecular IMaging”. This is a series
of conferences much like the Gordon Conferences in
the US or the original Keystone Symposia that runs
for a week. The overall concept is that experienced,
high-level scientists and younger scientists from
different disciplines are spending one week together
in an inspiring environment and to provide a
platform for knowledge exchange and discussion.
The TOPIM Meeting on Imaging Inflammation takes place on 1-6 February 2015 in Pichl near Schladming, Austria.
ENCITE Session at ECR 2014!
There will be an ENCITE dedicated public session at the ECR 2014!
Date: Sunday, March 9, 2014: 16:00-17:30
Venue: ECR 2014, Austria Center Vienna, Room P
Please find the programme as well as further information here .
Educational course on small animal MR Imaging
One of the successful educational ENCITE events in 2012 was the ESMRMB
Lecture on MR on Small Animal MRI. This year the course will be repeated under the auspices of ESMRMB and will take place in Münster/DE, October 10 - 12.
Successful conclusion of the ENCITE project
We are proud to announce that the ENCITE Project has been successfully concluded. We would like to thank everybody who contributed to this project. Please look out for the ENCITE special edition of Contrast Media & Molecular Imaging later this year.
Science to Practice
ENCITE cited in Science
Dual Contrast-enhanced MR Imaging to Monitor
for Rejection of Pancreatic Islet Transplantation?
Editorial in Radiogy by Olivier Clément/DESCARTES
Leiden debate focuses attention on future of imaging markers (AuntMinnie)
Hundreds of promising target molecules have been identified in
preclinical studies for possible use as novel cell imaging agents. But
how many are ever likely to be used in real patients? And who will pay
the costs of the clinical trials needed to prove their value? Enjoy reading the press article!